Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Proteostasis deficiencies
Amyloidosis
A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.
-
AL amyloidosis 92 trials · 98 incl. sub-types Sub-types →
-
Wild type ATTR amyloidosis 95 trials
-
Hereditary amyloidosis 19 trials · 79 incl. sub-types Sub-types →
-
ABeta2M amyloidosis 0 trials · 34 incl. sub-types Sub-types →
-
Primary cutaneous amyloidosis 4 trials · 5 incl. sub-types Sub-types →
-
AA amyloidosis 2 trials
-
Soft tissue amyloid neoplasm 1 trial
-
AApoAIV amyloidosis 0 trials
-
AH amyloidosis 0 trials
-
ALECT2 amyloidosis 0 trials
-
Amyloidosis bronchopulmonary 0 trials
-
Immunoglobulin heavy-and-light chain 0 trials